SEC Form 4 · accession 0001437749-16-023802
Oxford Immunotec Global PLC · OXFD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patricia Randall
Director
Period of report
Jan 15, 2016
Accepted (ET)
Jan 19, 2016 · 5:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001586049
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Jan 15, 2016 | M | 5,000 | $0.09 | A | 8,650 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SHARE OPTION (RIGHT TO BUY)F1 | $0.09 | Jan 15, 2016 | M | 5,000 | D | — | Feb 23, 2020 | Ordinary Shares | 5,000 | 15,074 | D |
Explanation of responses
- F1Became fully exercisable on April 1, 2014.